Wells Fargo & Company Myriad Genetics Inc Transaction History

Wells Fargo & Company

  • $433 Billion
  • Q4 2024

A detailed history of Wells Fargo & Company transactions in Myriad Genetics Inc stock. As of the latest transaction made, Wells Fargo & Company holds 214,127 shares of MYGN stock, worth $1.97 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
214,127
Previous 126,468 69.31%
Holding current value
$1.97 Million
Previous $3.46 Million 15.2%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
BUY
$13.17 - $27.03 $1.15 Million - $2.37 Million
87,659 Added 69.31%
214,127 $2.94 Million
Q3 2024

Nov 13, 2024
SELL
$23.97 - $28.6 $120,449 - $143,715
-5,025 Reduced 3.82%
126,468 $3.46 Million
Q2 2024

Aug 13, 2024
SELL
$17.98 - $25.47 $67,748 - $95,970
-3,768 Reduced 2.79%
131,493 $3.22 Million
Q1 2024

May 10, 2024
SELL
$17.59 - $23.59 $719,202 - $964,524
-40,887 Reduced 23.21%
135,261 $2.88 Million
Q4 2023

Feb 09, 2024
SELL
$13.91 - $21.32 $1.61 Million - $2.46 Million
-115,511 Reduced 39.6%
176,148 $3.37 Million
Q3 2023

Nov 13, 2023
SELL
$15.99 - $23.22 $187,802 - $272,718
-11,745 Reduced 3.87%
291,659 $4.68 Million
Q2 2023

Aug 15, 2023
SELL
$17.56 - $23.76 $51,696 - $69,949
-2,944 Reduced 0.96%
303,404 $7.03 Million
Q1 2023

May 12, 2023
BUY
$15.26 - $23.75 $970,047 - $1.51 Million
63,568 Added 26.18%
306,348 $7.12 Million
Q4 2022

Feb 13, 2023
SELL
$14.51 - $20.99 $1.63 Million - $2.35 Million
-112,175 Reduced 31.6%
242,780 $3.52 Million
Q3 2022

Nov 14, 2022
SELL
$18.21 - $27.88 $54,375 - $83,249
-2,986 Reduced 0.83%
354,955 $6.77 Million
Q2 2022

Aug 12, 2022
SELL
$16.45 - $25.88 $716,413 - $1.13 Million
-43,551 Reduced 10.85%
357,941 $6.5 Million
Q1 2022

May 16, 2022
BUY
$22.67 - $28.01 $1.25 Million - $1.55 Million
55,260 Added 15.96%
401,492 $10.1 Million
Q4 2021

Feb 14, 2022
SELL
$24.13 - $32.63 $1.95 Million - $2.64 Million
-80,860 Reduced 18.93%
346,232 $9.56 Million
Q3 2021

Nov 15, 2021
SELL
$29.97 - $36.66 $139,360 - $170,468
-4,650 Reduced 1.08%
427,092 $13.8 Million
Q2 2021

Aug 16, 2021
SELL
$25.39 - $32.61 $2.12 Million - $2.73 Million
-83,653 Reduced 16.23%
431,742 $13.2 Million
Q1 2021

May 13, 2021
SELL
$19.92 - $31.6 $584,432 - $927,112
-29,339 Reduced 5.39%
515,395 $15.7 Million
Q4 2020

Feb 09, 2021
SELL
$12.16 - $19.77 $213,420 - $346,983
-17,551 Reduced 3.12%
544,734 $10.8 Million
Q3 2020

Nov 05, 2020
BUY
$11.25 - $14.75 $139,770 - $183,254
12,424 Added 2.26%
562,285 $7.33 Million
Q2 2020

Aug 13, 2020
BUY
$10.69 - $16.49 $1.7 Million - $2.62 Million
158,720 Added 40.58%
549,861 $6.24 Million
Q1 2020

May 14, 2020
BUY
$9.78 - $29.53 $3.83 Million - $11.6 Million
391,141 New
391,141 $5.6 Million

Others Institutions Holding MYGN

# of Institutions
227
Shares Held
86M
Call Options Held
297K
Put Options Held
20.7K
View Full List

About MYRIAD GENETICS INC

MYGN Quotes by TradingView
  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $743M
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email